Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T15:30:01.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-13T14:40:31.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the preceding study details and document links with an access-denied message.
    Difference
    23%
    Check dated 2026-09-22T21:00:41.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    UPMC Hillman Cancer Center was added as a participating site, and the University of Pittsburgh Cancer Institute (UPCI) was removed. The study record revision was updated to version v3.7.0 (from v3.6.6).
    Difference
    0.2%
    Check dated 2026-09-15T20:32:10.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, indicating a new build behind the scenes. No study content or navigation changes are indicated.
    Difference
    0.0%
    Check dated 2026-09-01T19:54:24.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Date entries were added and older dates removed in the study record, updating the trial timeline and reporting milestones. These updates reflect administrative changes to scheduling and documentation rather than the study's scientific content.
    Difference
    0.2%
    Check dated 2026-08-18T20:00:17.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.